ARTICLE | Company News
Lion bioscience bioinformatics, genomics news
September 9, 2002 7:00 AM UTC
LEON said it will terminate its iD3 drug discovery business by the end of the year in order to focus on its bioinformatics business. LEON expects the move to save it up to $20 million annually. In June, LEON announced its intentions to seek alternatives for the information technology-based drug discovery unit (see BioCentury, June 10). ...